A series of novel organotin (IV) complexes on the base of 2-(N-3′, 5′-di-tert-butyl-4′-
hydroxyphenyl)-iminomethylphenol (L) of formulae Me2SnBr2 (L) 2 (1), Bu2SnCl2 (L) 2 (2) …

An optimal cancer chemotherapy regimen should effectively address the drug resistance of
tumors while eliciting antitumor‐immune responses. Research has shown that non …

Transition metal complexes have a great potential as therapeutic agents in the field of
oncology. Metals are necessary cellular components that are required for various vital …

The combination of one molecule of organic and metal-based fragments that exhibit
antitumor activity is a modern approach in the search for new promising drugs. In this work …

Multi‐drug resistance (MDR) is a major cause of cancer therapy failure. Photodynamic
therapy (PDT) is a promising modality that can circumvent MDR and synergize with …

We have prepared and characterized two Ru (III) compounds based on the 2, 2′-
biimidazole (H2biim) ligand, namely, a single complex of formula cis-[RuCl2 (H2biim) 2] Cl …

New organometallic iridium compounds with phosphorus modified glucose ligands
containing isopropylidene protection group or bearing uracil, thymine, and 5-fluorouracil (3 …

New ruthenium (ii) and ruthenium (iii) complexes with 2, 6-di-tert-butylphenol as the
antioxidant moiety were synthesized, and their antioxidant and antiproliferative activities …

Water-soluble nanoformulation of a hydrophobic anticancer PtIV complex with a lonidamine-
based ligand has been developed. Biodegradable nanocarriers (13 nm) obtained from poly …

Stability and narrow size distribution are among the main requirements that apply to drug
formulations based on polymeric nanoparticles. In this study, we obtained a series of …